News & Updates

Netarsudil use for glaucoma may cause punctal stenosis
Netarsudil use for glaucoma may cause punctal stenosis
28 Jun 2022

Use of topical netarsudil 0.02% for the treatment of glaucoma results in the development of reversible punctal stenosis, a recent study has found. This inflammation-mediated stenosis can cause tearing and related symptoms and may lead to treatment discontinuation with sufficient severity.

Netarsudil use for glaucoma may cause punctal stenosis
28 Jun 2022
Fatigue persists as lung function improves months after COVID-19 hospitalization
Fatigue persists as lung function improves months after COVID-19 hospitalization
28 Jun 2022 byStephen Padilla

COVID-19 patients remain on the recovery phase 6 months after hospital admission, with persistent fatigue but improving lung function and quality of life, according to a study.

Fatigue persists as lung function improves months after COVID-19 hospitalization
28 Jun 2022